Connect with us

Business

Burlington Stores' Drop Was An Overreaction

Published

on

Burlington Stores' Drop Was An Overreaction
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

Salesforce Stock Soars 19% as Blowout Earnings and Agentforce AI Growth Silence Software Skeptics

Published

on

Caterpillar Stock Drops Nearly 5% Friday as Investors Take Profits

SAN FRANCISCO — Salesforce shares surged Thursday, climbing as much as 19% to $244.72, after the enterprise software giant delivered a blowout quarterly earnings report that far exceeded Wall Street expectations and raised its full-year revenue guidance, driven largely by explosive growth in its Agentforce artificial intelligence platform.

The stock jumped $39.10 in trading Thursday morning, extending gains that began after the company reported its fiscal second-quarter results Wednesday evening. The move marked one of Salesforce’s strongest single-day performances in recent memory, following a report that Wall Street analysts described as its most convincing beat in several quarters.

A quarter that crushed estimates

Salesforce reported fiscal 2027 second-quarter revenue of $11.345 billion for the period ended July 31, up nearly 11% from a year earlier and slightly above Street estimates of roughly $11.32 billion. Adjusted earnings per share came in at $5.90, obliterating analyst expectations of around $3.27 per share, a beat of more than 80%.

Advertisement

Net income climbed to $3.53 billion, or $4.29 per diluted share, up 87% from $1.89 billion, or $1.96 per share, a year earlier. A significant portion of that jump was driven by a roughly $2.6 billion gain tied to Salesforce’s strategic investment in AI startup Anthropic, which was valued at $965 billion following a funding round earlier this year. Free cash flow also spiked 81% to $1.10 billion, well above the consensus estimate of about $643 million.

Agentforce becomes the story

While the headline numbers impressed investors, the bigger driver behind Thursday’s rally was Salesforce’s rapidly accelerating AI business. Annual recurring revenue from Agentforce and the company’s Data 360 platform reached nearly $3.9 billion, up more than 210% year over year, while Agentforce revenue alone exceeded $1.5 billion, growing more than 240% from the prior year.

Salesforce also reported that current remaining performance obligation, a forward-looking measure of contracted revenue expected to be recognized over the next year, reached $33.5 billion, topping analyst expectations of $33.22 billion, according to figures compiled by StreetAccount.

Advertisement

On the earnings call, Salesforce executives directly pushed back against skeptics who had questioned whether AI agents would disrupt the company’s traditional software business. One executive described a surge in AI-driven platform usage on the call, saying, “Agentic use of the platform surged sixfold via Model Context Protocol calls,” according to a transcript published by Investing.com. Executives also noted that customer attrition remained near its lowest level ever, seat counts across Agentforce, Sales, Service and Slack grew year over year, and contract lengths improved across all business segments — trends they framed as a direct rebuttal to fears that generative AI models would erode demand for traditional customer relationship management software.

Raised guidance adds fuel

Beyond the quarterly beat, Salesforce raised its full-year revenue guidance to a range of $46.1 billion to $46.4 billion, a signal to investors that management expects the current momentum in AI-related bookings to continue through the rest of the fiscal year. The company also announced an expanded partnership with Anthropic, deepening ties between the two companies as Salesforce continues integrating advanced AI models into its platform.

A stock that had fallen sharply before rebounding

Advertisement

Thursday’s surge represents a dramatic reversal for a stock that had struggled for much of 2026. As of Wednesday’s close, Salesforce shares were down roughly 22% year to date, even as the broader S&P 500 index had gained about 12% over the same period. That underperformance stemmed largely from investor anxiety earlier in the year that generative AI tools, including agentic systems built by companies like Anthropic, could render traditional enterprise software increasingly obsolete — fears that contributed to a broader roughly $2 trillion sell-off across software stocks industry-wide in early 2026.

Sentiment had already begun shifting in the weeks leading up to Thursday’s earnings report, however. Salesforce shares climbed 25% over the month heading into the report, fueled by growing investor confidence in Agentforce’s traction, alongside a $27.5 billion stock buyback program covering roughly 10% of the company’s fully diluted share count. Prediction market Polymarket had assigned a 91% probability to Salesforce beating earnings expectations ahead of Wednesday’s release, according to Yahoo Finance.

Part of a broader tech rally

Salesforce’s surge came amid a broader rally across technology stocks Thursday, as strong earnings from chipmaker Nvidia and cybersecurity firm CrowdStrike also lifted the sector. The combined strength across multiple high-profile tech earnings reports helped push the Nasdaq Composite higher in early trading, with investors treating the results as evidence that enterprise and consumer demand for AI-related products remains robust despite months of volatility in tech valuations.

Advertisement

What it means going forward

For Salesforce, Thursday’s rally represents a pivotal moment in the company’s yearslong effort to convince investors that its bet on AI agents can drive sustained growth rather than simply defend against disruption. With Agentforce annual recurring revenue more than tripling year over year and management projecting continued momentum through the rest of the fiscal year, the quarter offered some of the clearest evidence yet that the company’s AI strategy is translating into measurable financial results.

Still, analysts noted that the key question going forward is whether this quarter’s rapid growth can be sustained in the periods ahead, rather than representing a temporary surge tied to early enterprise adoption. Investors will be watching subsequent quarters closely for confirmation that Agentforce’s momentum can continue at a similar pace, particularly as competition in the enterprise AI space continues to intensify among software providers racing to integrate agentic capabilities into their platforms.

Advertisement
Continue Reading

Business

PM call to keep refugee numbers ‘not a backflip’

Published

on

PM call to keep refugee numbers 'not a backflip'

Yes. Corporate subscriptions are available for teams and organisations, with discounted rates as user numbers increase. Pricing starts from $1,625 + GST per user.
Get in touch
to discuss the right option for your organisation.

Business News subscriptions are used by executives, investors, consultants and professionals who need to stay informed and make better decisions about the WA market. When you subscribe you’ll get

  • Unlimited access to WA’s most trusted business journalism
  • Data & Insights — detailed profiles of WA companies, people, projects and deals
  • MyBN — a personalised feed based on the companies, people and sectors you follow
  • Special publications and industry reports
  • Daily and weekly email newsletters

Data & Insights is a research tool built specifically for the WA market. It draws on more than 30 years of Business News reporting, updated regularly to reflect what’s happening now. Use it to:

  • Look up detailed profiles of WA companies, including financials, directors and ownership
  • Find decision-makers and track their career movements
  • Research live and completed projects across WA industries
  • Monitor deals, appointments and market activity
  • Access industry rankings and league tables

Data & Insights is updated daily by our dedicated research team, which uses the latest announcements, ASX filings and editorial coverage to keep our person, company, list and project records up to date.

Business News welcome all opportunities to make our dataset accurate, complete and current, so if you have an update request, please email the team at
general@businessnews.com.au, and we’d be happy to assist.

Advertisement

MyBN
is part of every subscription. It’s your personalised view of Business News. You can follow the companies, people, sectors and projects that matter to you, and get a news feed and alerts tailored to your interests. You can save articles to read later and retain only what you need.

Only subscribers have full access to all content on the Business News website.

Advertisement

If staying informed about the WA economy is part of your job, and/or you’re looking for networking opportunities in WA, Business News is built for you.

Business News subscribers are:

  • Executives and directors tracking competitors, clients and market movements
  • Investors and advisers researching companies, deals and industry trends
  • Consultants and professionals staying across sectors relevant to their clients
  • Business owners looking for leads, context and market intelligence

Most Business News publications cover national or global markets. Business News is focused entirely on Western Australia, which means the journalism, the data and the intelligence are all built around WA companies, people and projects — not adapted from a national feed. Data & Insights, included with every subscription, combines more than 30 years of WA-specific editorial research with live business data. There’s no comparable product for the WA market.

Advertisement

The Morning Digest Email provides a comprehensive wrap of the major headlines, relevant to WA business, and includes with a snapshot of the overnight news covering oil, gold and ASX-listed companies.

The Afternoon Wrap Email focuses on the news covered by our team of journalists during the course of the working day, including exclusive stories and analysis, all of which relates to WA business and the local economy.

The BN Weekender Email contains a wrap of the Business News from the week that was, highlighting the top stories in each area of WA business.
Sign up for free.

Advertisement

We’re happy to help.
Get in touch
and our team will come back to you.

Advertisement
Continue Reading

Business

Selena Gomez pushes back against ‘frivolous’ fraud claims

Published

on

The female and male characters from the new Grand Theft Auto 6 game.

The investors claim they were told that “Selena Gomez, one of the most famous women on earth, with a billion-dollar brand and a platform unmatched in social media, would be actively building the company as its head of marketing”.

Gomez’s attorney Matthew Rosengart says their allegations are “vague, generalised and contradictory” and that Gomez never agreed to, and did not, manage the company, or make the kind of commitments they are suggesting.

The emphatic pushback from Gomez may reflect a concern for her reputation but it also leaves her mother in the hot-seat, facing the fraud allegations alongside the company itself and a third co-founder.

Crisis PR commentator, Lauren Beeching, founder of Honest London says Gomez is far from the first celebrity to try working with a close family member. At times it can come off like in the Jenner-Kardashian household or with the tennis-playing Williams sisters.

Advertisement

But there are plenty of examples – from the Beckhams’ to Britney Spears – where family brands and business don’t mix well.

Working with close relatives, whether that’s a sibling or a parent, or someone else is almost always a higher risk approach, says Beeching.

“It can make the boundaries between the personal relationship with the business and the celebrity’s reputation much harder to separate,” she says.

The natural level of trust means that you might not apply the same rules as you would in a normal commercial relationhsip, so better guardrails are needed, she says.

Advertisement

“If you’re going into business [as a] family, I’d put more structure around it, not less, for sure.

“Define everybody’s responsibilities, bring in independent oversight, and decide what happens if something goes wrong before something goes wrong.”

“A family relationship shouldn’t be a company’s governance structure.”

At the end of the day Gomez may not need to worry too much over this case, says Beeching

Advertisement

“This will generate headlines because Selena Gomez is enormously famous, but I don’t think it’s the type of story her core audience is particularly interested in.

“There’s an important difference between generating negative headlines and causing lasting reputational damage. “

Still, for celebrities considering trading on their personal brand, she does have words of advice.

“Before lending your name to a company, don’t ask what your reputation could do for the business. Ask what that business can eventually do for your reputation as well.”

Advertisement
Continue Reading

Business

Wall Street gains as investors cheer Nvidia’s forecast

Published

on

Wall Street gains as investors cheer Nvidia's forecast

Yes. Corporate subscriptions are available for teams and organisations, with discounted rates as user numbers increase. Pricing starts from $1,625 + GST per user.
Get in touch
to discuss the right option for your organisation.

Business News subscriptions are used by executives, investors, consultants and professionals who need to stay informed and make better decisions about the WA market. When you subscribe you’ll get

  • Unlimited access to WA’s most trusted business journalism
  • Data & Insights — detailed profiles of WA companies, people, projects and deals
  • MyBN — a personalised feed based on the companies, people and sectors you follow
  • Special publications and industry reports
  • Daily and weekly email newsletters

Data & Insights is a research tool built specifically for the WA market. It draws on more than 30 years of Business News reporting, updated regularly to reflect what’s happening now. Use it to:

  • Look up detailed profiles of WA companies, including financials, directors and ownership
  • Find decision-makers and track their career movements
  • Research live and completed projects across WA industries
  • Monitor deals, appointments and market activity
  • Access industry rankings and league tables

Data & Insights is updated daily by our dedicated research team, which uses the latest announcements, ASX filings and editorial coverage to keep our person, company, list and project records up to date.

Business News welcome all opportunities to make our dataset accurate, complete and current, so if you have an update request, please email the team at
general@businessnews.com.au, and we’d be happy to assist.

Advertisement

MyBN
is part of every subscription. It’s your personalised view of Business News. You can follow the companies, people, sectors and projects that matter to you, and get a news feed and alerts tailored to your interests. You can save articles to read later and retain only what you need.

Only subscribers have full access to all content on the Business News website.

Advertisement

If staying informed about the WA economy is part of your job, and/or you’re looking for networking opportunities in WA, Business News is built for you.

Business News subscribers are:

  • Executives and directors tracking competitors, clients and market movements
  • Investors and advisers researching companies, deals and industry trends
  • Consultants and professionals staying across sectors relevant to their clients
  • Business owners looking for leads, context and market intelligence

Most Business News publications cover national or global markets. Business News is focused entirely on Western Australia, which means the journalism, the data and the intelligence are all built around WA companies, people and projects — not adapted from a national feed. Data & Insights, included with every subscription, combines more than 30 years of WA-specific editorial research with live business data. There’s no comparable product for the WA market.

Advertisement

The Morning Digest Email provides a comprehensive wrap of the major headlines, relevant to WA business, and includes with a snapshot of the overnight news covering oil, gold and ASX-listed companies.

The Afternoon Wrap Email focuses on the news covered by our team of journalists during the course of the working day, including exclusive stories and analysis, all of which relates to WA business and the local economy.

The BN Weekender Email contains a wrap of the Business News from the week that was, highlighting the top stories in each area of WA business.
Sign up for free.

Advertisement

We’re happy to help.
Get in touch
and our team will come back to you.

Advertisement
Continue Reading

Business

Mach7 FY26 slides: reset year delivers cost cuts, recurring revenue shift

Published

on


Mach7 FY26 slides: reset year delivers cost cuts, recurring revenue shift

Continue Reading

Business

CrowdStrike Stock Jumps 18% After Blowout Earnings Beat and Raised Guidance Fueled by AI Security Demand

Published

on

CrowdStrike Stock Jumps 18% After Blowout Earnings Beat and Raised

AUSTIN, Texas — Shares of cybersecurity firm CrowdStrike Holdings surged Thursday, climbing as much as 17.69% to $222.64, after the company delivered stronger-than-expected fiscal second-quarter results and raised its full-year outlook, capping off what its chief executive called the best quarter in the company’s history.

The stock jumped $33.46 in Thursday’s trading session, extending gains that began Wednesday evening after CrowdStrike released its earnings report. The rally came as part of a broader wave of enthusiasm for software and cybersecurity stocks, with peers Salesforce and Okta also posting double-digit gains following their own quarterly reports released the same evening.

A quarter that beat across the board

CrowdStrike reported fiscal second-quarter revenue of $1.47 billion, up roughly 26% from $1.17 billion a year earlier and above Wall Street’s consensus estimate of $1.44 billion. Adjusted earnings per share came in at 31 cents, topping analyst expectations of 29 cents. Free cash flow reached $377.4 million, ahead of the $353 million analysts had projected.

Advertisement

Net new annual recurring revenue, a closely watched measure of new business growth for subscription-based software companies, surged 51% to a record $333 million, prompting the company to raise its full-year net new ARR growth outlook by 630 basis points, according to 24/7 Wall St.

Chief Executive George Kurtz described the results in stark terms in the company’s earnings release. “The best quarter in CrowdStrike’s history,” Kurtz said, crediting the company’s positioning in the fast-growing market for AI-related cybersecurity threats.

Raised guidance for the year ahead

Building on the strong quarterly print, CrowdStrike lifted its full-year revenue guidance to a range of $5.99 billion to $6.01 billion, up from a prior midpoint of roughly $5.94 billion, while raising its adjusted earnings per share outlook to between $1.25 and $1.26. For the current quarter, the company guided toward revenue of $1.52 billion to $1.53 billion, also ahead of the $1.51 billion analysts had expected.

Advertisement

AI threats driving demand

Much of the enthusiasm around CrowdStrike’s results centered on the company’s positioning at the intersection of two major technology trends: the rapid adoption of artificial intelligence across enterprises, and the corresponding rise in security risks that adoption creates. As companies increasingly deploy AI agents and automated systems across their operations, demand has grown for tools capable of protecting those systems from emerging threats — a dynamic CrowdStrike executives say is playing directly into the company’s favor.

The company also highlighted strong growth in its Falcon Flex offering, a platform that allows customers to deploy and swap between different security tools as needed. According to the earnings call, Falcon Flex adoption more than doubled from the prior year, with the company adding 935 new Flex accounts during the quarter — accounts that comprised its top 10 deals by value. Finance chief Burt Podbere told analysts on the call that the Flex model was helping the company win larger, longer-term contracts by allowing customers to purchase multiple products under a single platform.

A stock already on a hot streak

Advertisement

Thursday’s jump adds to what had already been an exceptional year for CrowdStrike shares. Heading into the earnings report, the stock had gained more than 63% year-to-date in 2026, far outpacing the S&P 500’s roughly 12% advance over the same period, according to Yahoo Finance. Shares had briefly surpassed a record $225 earlier in August before pulling back to around $186 ahead of Wednesday’s report, according to the Motley Fool.

That run-up had raised questions among some investors about whether the stock’s valuation, trading at more than 150 times forward earnings heading into the report, had already priced in much of the company’s anticipated growth. Ahead of the release, analysts at firms including Scotiabank, KeyBanc, Robert W. Baird, Mizuho Securities and J.P. Morgan had raised their price targets on the stock, reflecting growing confidence in the company’s AI-driven cybersecurity momentum, even as some cautioned the shares looked more like a hold than an aggressive buy given the premium valuation.

Part of a broader earnings wave

CrowdStrike’s report landed alongside a cluster of other closely watched technology earnings releases Wednesday evening, most notably Nvidia’s own blockbuster results, which dominated investor attention during the after-hours session. Salesforce and identity-security firm Okta also posted strong beats that evening, with Okta shares spiking as much as 18% and Salesforce climbing more than 21% in premarket trading Thursday, according to FXStreet and Yahoo Finance.

Advertisement

The broader earnings season has been unusually strong across the board. According to data from FactSet cited by Yahoo Finance, second-quarter earnings for S&P 500 companies are on pace to grow 50% year over year, the fastest growth rate since 2021, with Bank of America strategists pointing to artificial intelligence as the primary engine behind that broad-based strength.

With CrowdStrike’s stock now trading well above levels seen just a day earlier, attention turns to whether the company can sustain the pace of growth reflected in Thursday’s raised guidance through the remainder of its fiscal year. Investors will be watching upcoming quarters for confirmation that the surge in AI-related security demand, and the accompanying growth in products like Falcon Flex, represents a durable long-term trend rather than a temporary spike tied to the broader wave of enterprise AI adoption sweeping across corporate America this year.

For now, Thursday’s rally reinforced a theme that has run through much of this earnings season: companies positioned to benefit from the operational and security demands created by rapid AI adoption are being rewarded handsomely by investors, even as questions persist about how long the current pace of growth, and the elevated valuations that have accompanied it, can be sustained.

Advertisement
Continue Reading

Business

FDA approves Gilead HIV pill Bixlenvo designed to simplify treatment

Published

on

FDA approves Gilead HIV pill Bixlenvo designed to simplify treatment

Gilead Bixlenvo drug

Courtesy: Gilead

The Food and Drug Administration approved a once-daily HIV pill from Gilead that could help simplify care for some patients, the company announced Thursday. 

Advertisement

The drug, marketed as Bixlenvo, is aimed at patients whose virus is already under control but who remain on complicated treatment regimens. It could also appeal to those who simply want to switch to a new treatment alternative.

The tablet combines bictegravir, the backbone of Gilead’s blockbuster HIV pill Biktarvy, with lenacapavir, a first-in-class capsid inhibitor that has become a centerpiece of the company’s long-term strategy for HIV treatment and prevention. 

The approval makes the new pill the first single-tablet regimen available for adults with HIV whose virus is suppressed but are unable to use currently available one-pill treatment options, according to Gilead. That population accounts for an estimated 5% or more of individuals in the U.S. living with HIV, the company told CNBC. 

The list price of the pill before discounts or rebates is $4,595 for a 30-day supply, which is in line with other daily single-tablet HIV treatments, Gilead told CNBC. People without health insurance may be eligible to get Bixlenvo for free through Gilead’s patient assistance program, while those with commercial or private insurance may be able to receive co-pay support through another savings program, the company said.

Advertisement

“It fulfills an unmet need, particularly for individuals who are on complex regimens who just would not otherwise consolidate down to something really meaningful for them and prescribers,” Dr. Jared Baeten, Gilead’s clinical development and virology therapeutic area head, said in an interview ahead of the approval. 

“But it’s also meaningful for individuals who are seeking options for something new,” he continued. “We want to build options that give people the opportunity to choose something that’s going to work for them and work for them for the long haul.”

There is no cure for HIV or AIDS. But many people living with HIV can manage the disease by taking a single pill daily, a treatment plan that Gilead helped pioneer two decades ago. 

But some patients can’t use any existing one-tablet options like Biktarvy and require more complex combinations of medicines because of drug resistance from older therapies, side effects or interactions with other drugs, among other treatment challenges. Those patients may have to take multiple pills a day and adhere to complicated dosing schedules.

Advertisement

Baeten said that group tends to be older and have long treatment histories, saying “some had to take handfuls of pills around 25 years ago.” HIV also accelerates complications of aging, such as heart disease, diabetes and high cholesterol, in that age group, he added. 

“It’s incredibly meaningful to develop a medicine, in my perspective, for people aging with HIV,” Baeten said. 

The new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new one. Baeten stressed that Bixlenvo does not aim to replace Biktarvy. 

For patients already doing well on Biktarvy, the rationale for switching is more about expanding treatment choices, he said. He emphasized that HIV care is highly individualized and that long-term success often depends on finding a regimen that best fits a patient’s preferences and lifestyle.

Advertisement

Baeten also said Bixlenvo is part of Gilead’s broader effort to build a range of HIV treatment options around lenacapavir, including daily pills, weekly oral regimens and long-acting injectable therapies. The goal is to give patients flexibility to choose how they want to manage the disease, he said.

“We’re going to build enough options that people can make the choice that’s going to work for them,” Baeten said. “Some people like the surety of once a day, and some people would want ‘set it and forget it’ once every six months.”

What Bixlenvo is like for patients

Gilead Bixlenvo drug

Courtesy: Gilead

Advertisement

Baeten called it “essential” to have more than one medicine to treat HIV because the virus can become resistant to an initial treatment.

Combining bictegravir and lenacapavir in one pill allows it to “hit the virus in two different ways” with “high efficacy [and] strong protection” against the virus becoming resistant to treatment, Baeten added.

The approval is based on two Phase 3 trials, which evaluated Bixlenvo in adults with HIV whose virus was already suppressed on treatment. That includes people who switched from Biktarvy or complex treatment regimens with multiple tablets. 

The first trial – ARTISTRY-1 – specifically enrolled patients with long treatment histories and drug resistance, many of whom were taking multiple HIV medications each day. Participants had a median age of 60 and were taking between two and 11 pills daily before switching to Bixlenvo. 

Advertisement

In both studies, the pill maintained viral suppression at rates comparable to patients’ previous regimens at 48 weeks and was generally well tolerated with no new safety concerns. The most common side effects reported in at least 2% of participants across the two trials was headache, nausea and diarrhea. 

Timothy Cameron, a 64-year-old retired Seattle resident who has been living with HIV for more than 40 years, was among the participants in the first Phase 3 trial.

When he was first diagnosed in the 1980s, doctors had few treatment options and little ability to measure how active the virus was. He spent decades cycling through HIV medications, experimental drugs and multi-pill regimens that often came with difficult side effects and eventually stopped working against his “hard-to-treat” virus.

“It was just like throwing darts at a dartboard,” Cameron said. “Because I had done so many drug trials and monotherapy, my virus had become super resistant.”

Advertisement

A few years before enrolling in the Gilead study, Cameron finally found a regimen that controlled his virus, though it required taking one HIV pill twice daily along with another medication. His doctor encouraged him to join the trial and switch to Bixlenvo, a once-daily pill Cameron described as “smaller than my pinky nail.”

The transition was seamless, he said. The drug maintained control of his virus without causing side effects and simplified his treatment routine by reducing the number of pills he takes and consolidating all of his medications into a single daily schedule.

For Cameron, who spent decades exhausting HIV treatment options as his virus developed resistance, among the biggest benefits may be that the two-drug regimen effectively controls his virus while exposing him to fewer medications. He said that gives him confidence that additional treatment options could remain available in the future if he ever needs them.

“It’s one less thing I’m putting in my body, and it preserves options if I need them,” Cameron said.

Advertisement
Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
Continue Reading

Business

Pizza restaurants: Why pizza-making robots are not cutting it

Published

on

A robot arm hovers over a pizza

The robot pizza-making business has, it’s true, been littered with sorry tales of overcooked promises and melting fortunes. Besides Picnic, other companies that have come and gone include Zume, external and Pazzi, which used, external robot arms to assemble pizzas, as well as Basil Street, external, a purveyor of pizza vending machines.

Although so-called fast food might seem an easy target for automation, it’s proved harder than many expected. Plus, bringing robots into pizza restaurants could take away entry-level jobs in the hospitality sector. Is the future really filled with robotic pizza?

“We haven’t yet seen any of the success stories materialise the way some people thought they would,” admits Sara Senatore, senior restaurants analyst at Bank of America. Her employer has financial interests in multiple high street pizza chains including Papa Johns and Domino’s.

Food preparation bots are sometimes clumsy – dropping ingredients in the wrong places at times, she explains. Conversely, “Humans are very efficient at making pizza.”

Advertisement

But Kindell, despite his frustrations with Picnic, is surprisingly undeterred. He is a fan of full automation. “I want to be able to walk up to, let’s say, a type of kiosk, put in your order, and it makes a fresh pizza,” he tells the BBC.

Kindell, who once made all his dough by hand – until an elbow tendon injury forced him to investigate using machines instead, is now working on his own version of a pizza-making robot.

He declines to share details but the contraption will make square pan-style pies and that the machine is inspired by the way 3D printers work. If things go well, he says he could have a fully operational version of the device by the summer of 2027.

Given that he admits he has “no experience” in robotics, I question why he would want to invest in such a dicey business. Kindell says that failed pizza robot companies have nonetheless generated useful data and made strides in developing their technology. It’s just a matter of time before someone gets these things to work, he insists.

Advertisement

On jobs, he claims that even “fully autonomous” pizza robots won’t threaten workers. Kindell previously used Picnic’s robots at T-Mobile Park, home of the Seattle Mariners, a baseball team.

Usually, he’d need about 10 people to make pizza in such a setup. With the robots that number fell to just two. But the other eight people were still employed, he says, in roles where they interacted with customers, and advertised the pizza around the stadium.

“We had so many more people able to hand out the pizza,” says Kindell. “It was so much faster.”

Advertisement
Continue Reading

Business

The Big Four Recession Indicators: Real Personal Income

Published

on

The Big Four Recession Indicators: Real Personal Income

The Big Four Recession Indicators: Real Personal Income

Continue Reading

Business

An Oil Catastrophe Was Averted in 2026. What If It Comes in 2027?

Published

on

An Oil Catastrophe Was Averted in 2026. What If It Comes in 2027?

An Oil Catastrophe Was Averted in 2026. What If It Comes in 2027?

Continue Reading

Trending

Copyright © 2025